Sign In  |  Register  |  About Pleasanton  |  Contact Us

Pleasanton, CA
September 01, 2020 1:32pm
7-Day Forecast | Traffic

  • Search Hotels in Pleasanton

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ: VRTX )

458.18 +7.21 (+1.60%)
Streaming Delayed Price Updated: 10:02 AM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
53 54 Next >
The Ultimate Growth Stock to Buy With $1,000 Right Now
The positives are many and the negatives are few with this high-flying stock. 
Via The Motley Fool
2 Stocks That Could Crush the Market in 2024
These companies aren't slowing down, and their addressable markets are widening. 
Via The Motley Fool
Three S&P 500 Giants Lead This List Of Stocks Near Buy Points
Watch these five stocks, but the market is slightly extended. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Weight-Loss Drugs Have One Big Problem. These Drugmakers Are Taking It On.
Weight-loss drugs from Novo Nordisk and Eli Lilly lead to massive weight loss. But not all of that weight loss is healthy. 
Via Investor's Business Daily
The Best Stocks to Invest $5,000 in Right Now
These stocks could be huge winners for long-term investors. 
Via The Motley Fool
What Analysts Are Saying About Vertex Pharmaceuticals Stock
Via Benzinga
Stock-Split Watch: Is Vertex Pharmaceuticals Next?
It's on track to launch more blockbuster drugs. 
Via The Motley Fool
3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024
With new innovation and high demand, biotech stocks could offer some of the most explosive opportunities of the year. 
Via InvestorPlace
3 Secret Stocks to Double Your Money by 2028
Vertex Pharmaceuticals (VRTX), UiPath (PATH), and Science Applications International (SAIC) are 3 secret stocks to double your money by 2028. 
Via InvestorPlace
Vertex to Participate in Upcoming Investor Conferences
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Vertex Pharmaceuticals Is About to Extend Its Leadership in This Billion-Dollar Market
Vertex's main business may be heading for a new era of growth... 
Via The Motley Fool
Cathie Wood Is Betting on This Top Technology: 2 Stocks She Just Bought
These exciting players could deliver explosive growth over time. 
Via The Motley Fool
3 Revolutionary Biotech Stocks Poised for 10X Surge
Discover three biotech stocks set to soar in a $3.08 trillion market, merging medical innovations with financial growth opportunities. 
Via InvestorPlace
3 Magnificent Growth Stocks to Buy Right Now
These stocks share at least two common denominators: a biopharmaceutical focus and great long-term prospects. 
Via The Motley Fool
Could This News Upset Vertex Pharmaceuticals' Prospects in the Billion-Dollar Pain Management Market?
The pain market is in great need of new options. 
Via The Motley Fool
2 Top Growth Stocks to Buy With $1,000 Right Now
Even a modest starting investment in the right stocks could pay off in the years ahead. 
Via The Motley Fool
Vertex Pharmaceuticals Will Use $100 Million to Tank Its Own Market Share. Here's Why That's a Smart Move.
Sometimes, the winning move doesn't look right at first. 
Via The Motley Fool
2 Healthcare Growth Stocks That Are No-Brainer Buys Right Now
The healthcare industry often remains resilient amid macro headwinds, and these two stocks are prime examples. 
Via The Motley Fool
Giving Uber Its Due
We've also got a look at good news from Chipotle and Roblox, and we put some stocks on a dating show. 
Via The Motley Fool
Want $1 Million in Retirement? Invest $250,000 in These 3 Stocks and Wait a Decade.
These stocks have what it takes to drive superior returns in the years to come. 
Via The Motley Fool
Gene therapy: Why does it cost millions for a single treatment?
Gene therapy treatments have been making major headlines as advances in gene editing have gone mainstream thanks to the advent of CRISPR/Cas-9 technology. 
Via MarketBeat
Exposures Product Safety
Is Vertex Pharmaceuticals Stock Too Expensive With a Price-to-Sales Ratio of 11x?
There's more to consider with Vertex's valuation than one number. 
Via The Motley Fool
If You Invested $10,000 in Vertex Pharmaceuticals in 2014, This Is How Much You Would Have Today
You can't go back in the past, but it's not too late to invest in this top stock. 
Via The Motley Fool
European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia
From Vertex Pharmaceuticals Incorporated
Via Business Wire
2 Healthcare Stocks That Could Help Set You Up for Life
These rock-solid businesses can add meaningful returns to a long-term portfolio. 
Via The Motley Fool
3 Groundbreaking Healthcare Stocks to Buy for Robust Gains
Get the latest investment advice for healthcare stocks in 2024. Discover top picks and growth opportunities for the healthcare sector. 
Via InvestorPlace
Is Vertex Pharmaceuticals Stock a Buy Now?
The company just released its latest earnings report, and growth investors may be a little disappointed. 
Via The Motley Fool
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
These businesses are built to last. 
Via The Motley Fool
2 No-Brainer Healthcare Stocks to Buy Right Now
Companies in the healthcare industry tend to generate returns in a wide range of market environments. 
Via The Motley Fool
3 Stocks That Could Trounce the Market in 2024
These stocks appear to have what it takes to beat the market this year. 
Via The Motley Fool
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
53 54 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photography by Christophe Tomatis
Copyright © 2010-2020 Pleasanton.com & California Media Partners, LLC. All rights reserved.